Trial intelligence / Profile preview

Fortovase (Saquinavir) SGC TID + 2 NRTIs in HIV-1

NCT00002229Phase 4Completed

Sponsor
Roche
Modality
Small Molecules
Countries
3
01

Overview

Phase 4, open-label, single-arm trial of saquinavir in human immunodeficiency virus infection (HIV), sponsored by Roche. Status: completed.

02

Drugs

saquinavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00002229.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002229.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call